European Journal of Pharmacology

Top Research Topics at European Journal of Pharmacology?

The journal mainly tackles studies in Internal medicine, Endocrinology, Pharmacology, Receptor and Agonist. European Journal of Pharmacology features Internal medicine research that overlaps with concepts in Mechanism of action. It holds forums on Endocrinology that merges themes from other disciplines such as 5-HT receptor and Serotonin.

Pharmacology research featured in the journal incorporates concerns from various other topics such as Anesthesia, Biochemistry, In vivo and Opioid. Many of the studies tackled connect Receptor with a similar field of study like Binding site. The main emphasis of European Journal of Pharmacology is the subject of Nitric oxide, focusing on Nitric oxide synthase.

Presentations on Dopamine include those discussing Dopaminergic and Dopamine receptor.

• Internal medicine (54.69%)
• Endocrinology (52.45%)
• Pharmacology (30.60%)

What are the most cited papers published in the journal?

• Behavioural despair in rats: a new model sensitive to antidepressant treatments. (2682 citations)
• Cisplatin in cancer therapy: molecular mechanisms of action (2139 citations)
• The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review (2086 citations)

Research areas of the most cited articles at European Journal of Pharmacology:

The journal papers mainly deal with areas of study such as Internal medicine, Endocrinology, Pharmacology, Receptor and Agonist. The most cited publications link adjacent topics like Internal medicine with Mechanism of action. The most cited articles with studies in Endocrinology featured incorporate elements of Antagonist and 5-HT receptor, Serotonin.

What topics the last edition of the journal is best known for?

• Internal medicine
• Pharmacology
• Enzyme

The previous edition focused in particular on these issues:

The journal focuses on Pharmacology, Cancer research, Internal medicine, Endocrinology and Apoptosis. Research in In vivo and the interrelating topic of In vitro were among the subjects of interest in the Pharmacology studies discussed in European Journal of Pharmacology. Topics in Cancer research explored in the journal were investigated in conjunction with research in Cancer cell, Cancer, Metastasis, Downregulation and upregulation and Signal transduction.

Apoptosis research is the primary subject tackled in European Journal of Pharmacology with a focus on PI3K/AKT/mTOR pathway. The majority of Inflammation studies presented zero in on Proinflammatory cytokine. Agonist is a major topic of Receptor research presented in the journal.

The most cited articles from the last journal are:

• COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies. (88 citations)
• Functional and druggability analysis of the SARS-CoV-2 proteome. (22 citations)
• A review of potential suggested drugs for coronavirus disease (COVID-19) treatment. (16 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in European Journal of Pharmacology (based on the number of publications) are:

• Carlo Alberto Maggi (94 papers) absent at the last edition,
• Gian Luigi Gessa (86 papers) absent at the last edition,
• Geoffrey Burnstock (82 papers) absent at the last edition,
• Henry I. Yamamura (81 papers) absent at the last edition,
• Junzo Kamei (79 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in European Journal of Pharmacology (based on the number of publications) are:

• French Institute of Health and Medical Research (540 papers) absent at the last edition,
• National Institutes of Health (506 papers) published 2 papers at the last edition the same number as at the previous edition,
• Utrecht University (394 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• Karolinska Institutet (374 papers) published 1 paper at the last edition the same number as at the previous edition,
• Centre national de la recherche scientifique (314 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.48% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 2.13% were posted by at least one author from the top 10 institutions publishing in the journal. Another 3.55% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 4.26% of all publications and 90.07% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.